We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDC
701
DELISTED
Rowan Companies Plc
RDC
| $2.65M | 0.01% |
+229,306
| New | +$3.15M |
|
702
Wells Fargo
WFC
$265B
| $2.59M | 0.01% |
+49,449
| New | +$2.94M |
|
|
TARO
703
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $2.58M | 0.01% |
26,091
-79,850
| -75% | -$8.09M |
|
704
Travelers Companies
TRV
$78.3B
| $2.56M | 0.01% |
18,400
+14,300
| +349% | +$2M |
|
|
TBHC
705
DELISTED
The Brand House Collective
TBHC
| $2.55M | 0.01% |
263,607
| – | – |
|
|
BMS
706
DELISTED
Bemis
BMS
| $2.55M | 0.01% |
+58,600
| New | +$2.67M |
|
707
Cass Information Systems
CASS
$734M
| $2.52M | 0.01% |
50,886
| – | – |
|
708
Bio-Rad Laboratories Class A
BIO
$9.48B
| $2.5M | 0.01% |
10,000
+1,200
| +14% | +$306K |
|
|
TACO
709
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $2.5M | 0.01% |
241,412
+110,948
| +85% | +$1.37M |
|
|
VRS
710
DELISTED
Verso Corporation
VRS
| $2.49M | 0.01% |
148,040
-60,224
| -29% | -$1.01M |
|
|
HOME
711
DELISTED
At Home Group Inc.
HOME
| $2.48M | 0.01% |
77,557
-5,000
| -6% | -$154K |
|
712
Travere Therapeutics
TVTX
$5.74B
| $2.48M | 0.01% |
110,714
+76,700
| +225% | +$1.83M |
|
|
CHUBA
713
DELISTED
CommerceHub, Inc. Series A Common Stock
CHUBA
| $2.45M | 0.01% |
108,782
-97,220
| -47% | -$2.03M |
|
|
KL
714
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $2.43M | 0.01% |
156,900
-762,621
| -83% | -$11.7M |
|
|
AXIA
715
DELISTED
AXIA Energia
AXIA
| $2.42M | 0.01% |
481,665
+438,701
| +1,021% | +$2.26M |
|
716
Factset
FDS
$10.1B
| $2.41M | 0.01% |
+12,100
| New | +$2.44M |
|
717
Kosmos Energy
KOS
$1.49B
| $2.41M | 0.01% |
383,013
-580,552
| -60% | -$3.64M |
|
718
Bausch Health
BHC
$2.37B
| $2.4M | 0.01% |
+151,100
| New | +$2.81M |
|
|
NBIS
719
Nebius Group N.V.
NBIS
$46.7B
| $2.4M | 0.01% |
+60,900
| New | +$2.39M |
|
720
Embotelladora Andina Series B
AKO.B
$4.95B
| $2.39M | 0.01% |
81,623
| – | – |
|
721
Golub Capital BDC
GBDC
$3.41B
| $2.38M | 0.01% |
135,951
-512,171
| -79% | -$9.07M |
|
722
AstraZeneca
AZN
$251B
| $2.37M | 0.01% |
33,905
-332,886
| -91% | -$23.1M |
|
723
NetApp
NTAP
$39B
| $2.35M | 0.01% |
+38,100
| New | +$2.33M |
|
|
IMOS
724
ChipMOS TECHNOLOGIES
IMOS
$1.84B
| $2.35M | 0.01% |
125,632
+29,984
| +31% | +$613K |
|
725
Manhattan Associates
MANH
$11.4B
| $2.35M | 0.01% |
+56,000
| New | +$2.61M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.